Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Fujimiya is active.

Publication


Featured researches published by Hiroshi Fujimiya.


Biochemical and Biophysical Research Communications | 1991

Antigen-induced biphasic diacylglycerol formation in RBL-2H3 cells: The late sustained phase due to phosphatidylcholine hydrolysis is dependent on protein kinase C

Shigeru Nakashima; Hiroshi Fujimiya; Hideo Miyata; Yoshinori Nozawa

Exposure to antigen (Ag) caused a biphasic 1,2-diacylglycerol (DG) production in [3H]myristic acid-labeled RBL-2H3 cells; the early, small transient phase and the second large sustained phase. The accumulation of phosphatidic acid (PA) or phosphatidylethanol (PEt) in the presence of ethanol was paralleled by the second-phase DG generation. Ag-induced formation of phosphocholine and choline in [3H]choline-labeled cells suggested the hydrolysis of phosphatidylcholine (PC) by phospholipases C and D. Treatment with phorbol myristate (PMA) or A23187 caused increases in [3H]DG and water-soluble [3H]choline metabolites. In protein kinase C (PKC) down-regulated cells, PEt formation was markedly reduced. In these cells DG production induced by Ag and A23187 was largely suppressed, thus indicating that PKC would play an important regulatory role for PC hydrolysis. However, because the A23187 treatment showed significant accumulation of water-soluble choline metabolites in PKC down-regulated cells, an increase in intracellular Ca2+ is another factor regulating PC hydrolysis. Taken together, these results may indicate that PC hydrolysis in response to Ag is dependent on PKC and Ca2+.


International Archives of Allergy and Immunology | 1991

Effect of a Novel Antiallergic Drug, Pemirolast, on Activation of Rat Peritoneal Mast Cells: Inhibition of Exocytotic Response and Membrane Phospholipid Turnover

Hiroshi Fujimiya; Shigeru Nakashima; Hideo Miyata; Yoshinori Nozawa

The effects of a potent antiallergic drug, pemirolast (TBX), on activation of signal-transducing phospholipase C and A2, were examined in rat peritoneal mast cells. TBX at concentrations between 10(-7) and 10(-5) g/ml effectively inhibited degranulation in response to both antigen and compound 48/80. At the same concentrations the drug markedly suppressed the formation of 1,2-diacylglycerol and phosphatidic acid, and the decrease in phosphatidylinositol, suggesting the prevention of phospholipase C activation. The blockade of phospholipase A2 was suggested by the decrease in agonists-induced arachidonic acid liberation. These results indicate that TBX may exert its inhibitory effects on mast cells, at least in part, by preventing the activation of signal-transducing phospholipases.


Equilibrium Research | 1987

Actual situation of balance disordered persons recognized in the Law for the Welfare of Physically Disabled Persons

Mami Kotaka; Hideo Miyata; Yuka Kondou; Miyako Takahashi; Hikari Koizumi; Yoshiro Mori; Michitoshi Ohno; Hiroshi Fujimiya; Takashi Tokita

1) The data published by the Welfare Ministry and the Gifu prefectural office were analyzed with respect to persons with balance disorders. Balance disorders account for only 0.1 percent to 0.2 percent of all physical disabilities.2) The number of, persons with balance disorders living in Gifu prefecture is 81.3) The causes of the balance disorder in these 81 persons were : labyrinth or eighth cranial nerve damage (31), CNS disturbance (42), combined disturbance of the labyrinth and CNS (4), and unknown (4).4) Persons under 18 years or 60 years of age had mainly CNS disturbances.5) The incidence of multiple handicaps, especially balance disorder plus deafness, was higher in the labyrinth and the eighth cranial nerve damage group than in the CNS disturbance group.6) Grade 5 balance disorder was more common than grade 3 in the labyrinth and the eighth cranial nerve damage group. The number of grade 3 and grade 5 balance disorders was approximately equal in the CNS disturbance group.


Arerugī (Allergy) | 1994

An antiallergic drug, pemirolast potassium, inhibits inositol 1,4,5-trisphosphate production and Ca2+ mobilization in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells.

Hiroshi Fujimiya; Shigeru Nakashima; Takahiko Kumada; Yoshikatsu Nakamura; Hideo Miyata; Yoshinori Nozawa


Arerugī (Allergy) | 1995

Effects of an antiallergic drug, pemirolast potassium on tyrosine phosphorylation and map kinase activation in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells.

Yoshikatsu Nakamura; Shigeru Nakashima; Hiroshi Fujimiya; Takahiko Kumada; Yukihiro Kato; Hideo Miyata; Yoshinori Nozawa


Arerugī (Allergy) | 1995

[Effects of antiallergic drug, pemirolast potassium on phospholipase D activation in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells].

Yoshikatsu Nakamura; Shigeru Nakashima; Hiroshi Fujimiya; Takahiko Kumada; Ojio K; Hideo Miyata; Yoshinori Nozawa


Practica oto-rhino-laryngologica | 1997

Efficacy of Alegysal in Relation to the Amount of Japanese Cedar and Japanese Cypress in the Air.

Hirotaka Ito; Ippei Takagi; Syunkichi Baba; Hiroshi Fujimiya; Keisuke Mizuta; Hideo Miyata; Tadao Nishimura; Atsushi Usami


Equilibrium Research | 1993

Studies on Caloric Nystagmus and Optokinetic Nystagmus in Elderly Japanese

Keisuke Mizuta; Shinji Sakuma; Toshimi Kojima; Hiromichi Shirato; Shigeo Sawai; Mitsuhiro Aoki; Masahiko Yamada; Hiroshi Fujimiya; Yatsuji Ito; Hideo Miyata


Equilibrium Research | 1993

Evaluation of Treatment of Vestibular Vertigo

Takahiro Yamada; Toshimi Kojima; Shigeo Sawai; Keisuke Mizuta; Yatsuji Ito; Takahiko Kumada; Hiroshi Fujimiya; Hideo Miyata


Arerugī (Allergy) | 1993

[IgE-receptor stimulation induces biphasic 1,2-diacylglycerol production in RBL-2H3 cells. Phosphatidylcholine hydrolysis by phospholipase D plays a major role in the second sustained 1,2-diacylglycerol accumulation].

Hiroshi Fujimiya; Hideo Miyata; Shigeru Nakashima; Yoshinori Nozawa

Collaboration


Dive into the Hiroshi Fujimiya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge